Stockscreener 앱 받기
20.01
8.10%
1.50
시간 외 거래:
20.09
0.08
+0.40%
Sanara Medtech Inc 주식(SMTI)의 최신 뉴스
SMTI Initiates Coverage On Lake Street -- Rating Set to Buy - GuruFocus
Sanara MedTech outlines 2026 net revenue guidance of $116M–$121M while expanding distributor network and product reach - MSN
Baird entities report 21,075 shares in Sanara MedTech (SMTI) Schedule 13G/A - Stock Titan
Sanara MedTech to Report Q1 2026 Earnings on May 12 - National Today
Sanara MedTech Inc. to Report First Quarter 2026 Financial Results on May 12, 2026 - The Manila Times
Sanara MedTech sets May 12 webcast for first-quarter 2026 results - Stock Titan
Sanara MedTech Faces Securities Fraud Probe After Tissue Health Plus Shutdown - National Today
Aug Analyst Calls: Does Sanara MedTech Inc have pricing power2026 Spike Watch & Fast Exit and Entry Strategy Plans - baoquankhu1.vn
EV Market: Can Sanara MedTech Inc grow without external funding2026 Institutional Moves & Weekly Watchlist of Top Performers - baoquankhu1.vn
Inflation Data: Whats next for Sanara MedTech Inc stock2026 Technicals & Growth Focused Entry Point Reports - baoquankhu1.vn
Sanara MedTech Investigated for Potential Securities Fraud - National Today
Sanara MedTech, Inc. Investigated by the Portnoy Law Firm - GlobeNewswire
Volume Recap: How does Sanara MedTech Inc correlate with Nasdaq2026 Biggest Moves & High Win Rate Trade Alerts - baoquankhu1.vn
Trading the Move, Not the Narrative: (SMTI) Edition - Stock Traders Daily
Chart Watch: Is Sanara MedTech Inc stock a top performer YTDSell Signal & Reliable Intraday Trade Alerts - baoquankhu1.vn
Tech Rally: Is Sanara MedTech Inc vulnerable to short sellers2026 Stock Rankings & Consistent Growth Equity Picks - baoquankhu1.vn
Q1 EPS Estimates for Sanara MedTech Lowered by HC Wainwright - Defense World
SMTI Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Momentum Shift: Can Sanara MedTech Inc grow without external fundingRecession Risk & Smart Money Movement Alerts - baoquankhu1.vn
H.C. Wainwright reiterates Sanara MedTech stock rating at buy By Investing.com - Investing.com Canada
Sanara MedTech (NASDAQ:SMTI) Lowered to Hold Rating by Wall Street Zen - Defense World
Reviewing Sanara MedTech (NASDAQ:SMTI) & ICU Medical (NASDAQ:ICUI) - Defense World
Q4 EPS Estimates for Sanara MedTech Decreased by Analyst - MarketBeat
Recap Report: Is Sanara MedTech Inc undervalued by DCF analysis2026 Top Decliners & Stepwise Swing Trade Plans - baoquankhu1.vn
Aug Chart Watch: Is Sanara MedTech Inc showing insider buying2026 Technicals & Reliable Entry Point Alerts - baoquankhu1.vn
(SMTI) Volatility Zones as Tactical Triggers - Stock Traders Daily
Sanara MedTech Q4 2025 Earnings Call Transcript - MarketBeat
Sanara MedTech Earnings Call Signals Growth Momentum - The Globe and Mail
Sanara MedTech (NASDAQ:SMTI) Upgraded by Wall Street Zen to Buy Rating - MarketBeat
Sanara MedTech shares rise more than 3% despite fourth-quarter earnings miss - MSN
Sanara MedTech Inc. (NASDAQ:SMTI) Q4 2025 Earnings Call Transcript - Insider Monkey
Retail Trends: Can Sanara MedTech Inc maintain sales growth2026 Technical Patterns & AI Forecasted Entry and Exit Points - baoquankhu1.vn
Sanara MedTech Hits 52-Week Low of $17.54 Amidst Market Struggles - Markets Mojo
Sanara MedTech Inc. Q4 2025 Earnings Call Summary - finance.yahoo.com
Sanara MedTech Reports Strong 2025 Financial Results With 19% Revenue Growth, Reaffirms 2026 Guidance - Minichart
Sanara MedTech (SMTI) to Release Quarterly Earnings on Wednesday - MarketBeat
Sanara MedTech Inc. 2025 Business Overview: Surgical Product Focus, Innovation Strategy, and Regulatory Compliance - Minichart
Sanara MedTech Inc. (SMTI) Q4 earnings miss estimates - MSN
Sanara MedTech Inc (SMTI) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ... By GuruFocus - ca.investing.com
Sanara MedTech (NASDAQ: SMTI) ends THP unit, doubles down on surgery - Stock Titan
Sanara MedTech Inc (SMTI) Q4 2025 Earnings Call Highlights: Reco - GuruFocus
Sanara MedTech stock rises over 3% despite fourth quarter miss By Investing.com - Investing.com India
Targets Report: Can Sanara MedTech Inc deliver consistent dividends2026 Market Sentiment & Fast Entry High Yield Stock Tips - baoquankhu1.vn
Sanara MedTech Inc. (SMTI) Q4 and Full Year 2025 Earnings: Revenue Hits $103.1 Million With 19% Growth - Bayelsa Watch
Earnings Call Summary | Sanara MedTech(SMTI.US) Q4 2025 Earnings Conference - 富途牛牛
Sanara Medtech earnings missed by $0.52, revenue fell short of estimates - Investing.com Canada
Earnings call transcript: Sanara MedTech Q4 2025 misses EPS forecast, stock drops - in.investing.com
Sanara MedTech Inc. (SMTI) Q4 Earnings: Misses on EPS, Revenue Recap - AlphaStreet
Sanara MedTech Q4 Earnings Call Highlights - Yahoo Finance
Sanara MedTech Inc. (SMTI) Misses Q4 EPS Estimates by 215.9% - AlphaStreet
Sanara MedTech Inc. (SMTI) Q4 Earnings Miss Estimates - Yahoo Finance
Sanara Medtech Inc. Reaffirms Revenue Guidance for the Full Year Ending December 31, 2026 - MarketScreener
Sanara MedTech stock rises over 3% despite fourth quarter miss - Investing.com
Sanara MedTech Inc. Reports Fourth Quarter (Unaudited) and Full Year 2025 Financial Results; Reaffirmed Full Year 2026 Financial Guidance - The Manila Times
Sanara MedTech reports FY2025 revenue $103.1M, Q4 revenue $27.5M and Adjusted EBITDA $17.0M - TradingView
Sanara MedTech posts higher Q4 revenue, reaffirms guidance - TradingView
Sanara MedTech Inc. Reports Fourth Quarter (Unaudited) and - GlobeNewswire
Sanara MedTech Inc. (SMTI) Q4 Results Fall Short of Projections - Bitget
Sanara MedTech (SMTI) CEO receives 25,430-share restricted stock grant vesting through 2029 - Stock Titan
Sanara MedTech (SMTI) grants restricted stock to controller vesting through 2029 - Stock Titan
0.06%
1.84%
자본화:
|
볼륨(24시간):